New open-label data from the expanded-access treatment program involving the cannabidiol Epidiolex (GW Pharma) show the median reduction in frequency of convulsive seizures after 3 months of treatment was 45% in all patients but higher in those with Dravet syndrome, among the most severe types of epilepsy. The data are “very positive and promising,” said […]
Co-morbidities in a Hong Kong Cohort People with epilepsy have a higher prevalence of psychiatric and medical comorbid conditions than the general population. Now a recent review of patients with newly diagnosed and treated epilepsy admitted to Hong Kong hospitals has revealed that even patients without a long history of epilepsy have increased morbidity and […]
As many as one out of four adults who suffer from epilepsy do not respond to any available drugs. That makes the search for effective new anti-seizure medications vital, and Carnegie Mellon University chemist Maria Kurnikova is playing a key role in that quest. Kurnikova, an associate professor of chemistry, is part of a team […]
A new study undertaken jointly by researchers from the Sagol Department of Neurobiology at the University of Haifa and European researchers, published in the journal Cerebral Cortex, exposes a new biological mechanism that, on the one hand, damages a very specific type of memory, but at the same time provides resistance to epilepsy.
Mutations in a gene called SCN2A have opposite effects in autism and in epilepsy. The divergence makes the gene an attractive candidate for research, suggest unpublished results presented today at the 2016 Society for Neuroscience annual meeting in San Diego.
Rheumatoid arthritis is an autoimmune disease whereby the body’s own immune system attacks the joints. New research suggests there may be a link between mothers with the autoimmune disorder and their children who develop epilepsy.